Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Mar;84(3):418-467.
doi: 10.1016/j.jinf.2021.10.009. Epub 2021 Oct 20.

Persistence at one year of neutralizing antibodies after SARS-CoV-2 infection: Influence of initial severity and steroid use

Olivier Epaulard  1 , Marlyse Buisson  2 , Benjamin Nemoz  3 , Marion Le Maréchal  4 , Nicolas Terzi  5 , Jean-François Payen  6 , Marie Froidure  4 , Myriam Blanc  4 , Anne-Laure Mounayar  4 , Fanny Quénard  4 , Isabelle Pierre  4 , Patricia Pavese  4 , Raphaele Germi  3 , Laurence Grossi  3 , Sylvie Larrat  3 , Pascal Poignard  3 , Julien Lupo  3
Affiliations
Comment

Persistence at one year of neutralizing antibodies after SARS-CoV-2 infection: Influence of initial severity and steroid use

Olivier Epaulard et al. J Infect. 2022 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest Siemens Healthineers for Atellica sCOVG reagents offered free of charge.

Figures

Fig 1
Fig. 1
Quantitative detection of SARS-CoV-2 IgG antibodies by Atellica serology (a) and neutralising antibody titres (b) at the two sample dates according to vaccination between the two titres (grey: no vaccination, black: vaccination). (The samples with no detectable antibodies are below the X axis).
Fig 2
Fig. 2
Neutralizing antibody titres at the two sampling dates according to severity, steroid use, and (for the second date) vaccination (black triangles) or not (white triangles). (The two samples with no detectable NAbs are figured above the X axis with an arrow).
See this image and copyright information in PMC

Comment on

References

    1. Thangaraj J.W.V., Kumar M.S., Kumar C.G., et al. Persistence of humoral immune response to SARS-CoV-2 up to 7 months post-infection: cross-sectional study, South India, 2020-21. J Infect. 2021;83(3):381–412. - PMC - PubMed
    1. Bal A., Brengel-Pesce K., Gaymard A., et al. Clinical and laboratory characteristics of symptomatic healthcare workers with suspected Covid-19: a prospective cohort study. Sci Rep. 2021;11(1):14977. - PMC - PubMed
    1. Bergwerk M., Gonen T., Lustig Y., et al. Covid-19 breakthrough infections in vaccinated health care workers. N Engl J Med. 2021:1474–1484. Under press. - PMC - PubMed
    1. Xiang T., Liang B., Fang Y., et al. Declining levels of neutralizing antibodies against SARS-CoV-2 in convalescent Covid-19 patients one year post symptom onset. Front Immunol. 2021;12 - PMC - PubMed
    1. Wisnivesky J.P., Stone K., Bagiella E., et al. Long-term persistence of neutralizing antibodies to SARS-CoV-2 following infection. J Gen Intern Med. 2021;36(10):3289–3291. - PMC - PubMed